OUR MISSION

Revolutionizing the Approach to Spine Surgery

ATEC is more than a medical technology company. We are an Organic Innovation Machine™ that is focused on Revolutionizing the Approach to Spine Surgery. We are committed to creating clinical distinction by developing new approaches to treat the various pathologies to ultimately achieve the goals of spine surgery. Our ultimate vision is to become The Standard-Bearer in Spine.

stand·ard-bear·er

/ˈstandərd ˌberər/

  • A leading figure in a cause or movement.

ATEC is committed to delivering improved patient care, and our strengths are derived through our ability to embody our Core Values.

Mission

Revolutionizing the Approach to Spine Surgery

Vision

The Standard-Bearer in Spine

Values

- Deliver high performance

- Demonstrate GRIT

- Be constantly curious

- Commit to clinical distinction

- Be gracious, familial, & inspire others

- Love what you do

- #ATECPROUD

Dr. Pimenta

Profound Curiosity

ATEC is focused on developing new standards for spine surgery regardless of surgical approach. With so much variation in spine surgery today, there is a great opportunity for ATEC to deliver new approaches that achieve the goals of surgery –decompression, stabilization, and alignment.

 

Luiz Pimenta MD, PhD
Chief Medical Officer

A Message from Our Leadership

Leadership

Executive Team

Pat Miles

Patrick S. Miles

Chairman and Chief Executive Officer

 

PATRICK S. MILES


Chairman and Chief Executive Officer

Patrick S. Miles has served as Chairman and Chief Executive Officer of Alphatec Holdings and Alphatec Spine since October 2017. Mr. Miles has over 20 years of experience in the orthopaedic industry and most recently served, from September 2016 to September 2017, as the Vice Chairman of NuVasive. As Vice Chairman, Mr. Miles was responsible for enhancing the Company’s strategic plans for the future of spine surgery and supporting technology development. Mr. Miles served as a member of NuVasive’s Board of Directors since August 2016 until his resignation in September 2017. Prior to that, Mr. Miles served as NuVasive’s President and Chief Operating Officer from February 2015 to September 2016. He previously served as NuVasive’s President of Global Products and Services from October 2011 to January 2015, President of the Americas from January 2010 to September 2011, Executive Vice President of Product Marketing and Development from January 2007 to December 2009, Senior Vice President of Marketing from December 2004 to January 2007, and as its Vice President, Marketing from January 2001 to December 2004. Prior to those positions, he served as Director of Marketing for ORATEC Interventions, Inc., a medical device company, and as a Director of Marketing for Minimally Invasive Systems and Cervical Spine Systems for Medtronic Sofamor Danek, and held several positions with Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.

Craig Hunsacker

Craig Hunsaker

Executive Vice President, People & Culture

CRAIG HUNSAKER


Executive Vice President, People & Culture

Craig Hunsaker has served as Executive Vice President, People & Culture since September 2016. In this role, he is responsible for all aspects of employee recruitment, development, engagement and corporate culture. Craig also served as the Company’s General Counsel & Corporate Secretary from March 2017 to July 2023.  Craig's professional career includes 16 years practicing law at some of the world's largest technology focused law firms, advising and defending companies and management with respect to their people and trade secrets decisions, while holding various leadership positions. Craig left full-time legal practice in 2009, when he joined NuVasive, Inc., a publicly traded spinal implant company, first to serve as Vice President, Legal Affairs, then as Senior Vice President, Global Human Resources until March 2014.  From April 2014 until he joined ATEC, Craig owned a consulting business, assisting employers in the areas of Employment Law and Human Resources, including as Senior Advisor, Human Resources at General Atomics, a San Diego-based defense contractor. Craig received his J.D. from Columbia University School of Law, where he was a Harlan Fiske Stone Scholar, and his B.S. in International Business & Finance from Brigham Young University.

Todd-Koning-Headshot-copy

Todd Koning

Chief Financial Officer

 

TODD KONING


Chief Financial Officer

Todd Koning has served as Executive Vice President and Chief Financial Officer since April 2021. He brings over 20 years of focused medical device finance, accounting, and international experience. His ATEC appointment follows three years with Masimo Corporation, where he most recently served as Senior Vice President of Finance and Chief Accounting Officer, responsible for corporate planning and analysis, global accounting, SEC reporting, financial systems, and investor outreach. Prior to his role at Masimo, Todd served as Vice President of Finance at NuVasive, Inc. and Vice President of Finance at Ellipse Technologies, Inc., which was acquired by NuVasive in 2016. He also held various domestic and international finance and accounting leadership roles at Boston Scientific Corporation and Guidant Corporation. Todd holds an M.B.A. from Purdue University and a B.S. in Engineering from Michigan State University.

Eric Dasso

Eric Dasso

Executive Vice President, Adjunctive Technologies

 

ERIC DASSO


Executive Vice President, Adjunctive Technologies

Eric Dasso has served as Executive Vice President, Adjunctive Technologies since August 2019.  Prior to joining the Company, Mr. Dasso held various marketing leadership and global product management roles within NuVasive, Inc. from 2001 to 2018.  He most recently served as NuVasive’s Vice President, Global Implant Systems (February 2015 to June 2018), which included overall responsibility for that company’s product development, commercialization and marketing functions of its $750M global implant franchise.  Prior to leading Global Implant Systems, Mr. Dasso over saw the marketing and development of NuVasive’s thoracolumbar portfolio in various roles of increasing responsibility from February 2005 to February 2015, including as Project Manager, Thoracolumbar Fixation (February 2005 to July 2007), Senior Project Manager, Thoracolumbar Fixation (July 2007 to September 2008), Director, Marketing, Thoracolumbar Fixation (September 2008 to June 2010), Senior Director, Thoracolumbar (June 2010 to January 2014) and as Vice President, Thoracolumbar Posterior (January 2014 to February 2015).  Prior to Nuvasive, Mr. Dasso held various positions at Johnson and Johnson and Acxiom Inc.  Mr. Dasso received a bachelor’s degree in Business Administration from California Polytechnic State University—San Luis Obispo.

scott-lish_new_web

SCOTT LISH

Chief Operating Officer

 

 

Scott Lish


Chief Operating Officer

Scott Lish has served as Chief Operating Officer since January 2024. Mr. Lish began his career at ATEC in October 2017 as Vice President, Research and Development and was promoted to Senior Vice President, Research and Development in October 2020. Prior to joining NuVasive, Mr. Lish worked for 2 years as a Manufacturing Engineer for Zimmer Dental. Mr. Lish received an M.S. degree in Material Science and a B.E. degree in Mechanical Engineering from the Thayer School of Engineering at Dartmouth, as well as a B.A. degree in Engineering Sciences from Dartmouth College.

David Sponsel

Dave Sponsel

Executive Vice President, Sales

 

       

DAVE SPONSEL


Executive Vice President, Sales

Dave Sponsel has served as Executive Vice President, Sales since April 2019. Dave began his career at Alphatec Spine as Area Vice President, Sales, South in May 2018. Prior to joining Alphatec Spine, he held the position of General Manager, Spine Division for Medacta, USA, where he was responsible for sales, marketing, product management and product development. Prior to that, he had an exceedingly successful 11-year experience in sales and sales leadership with Stryker Spine, where he was recognized as Sales Director of the Year in 2014. Dave received a BS from Indiana State University in Business Management.

Ali Shorooghi Senior Vice President, Marketing

Ali Shorooghi

Senior Vice President,

Marketing

Ali Shorooghi


Senior Vice President, Marketing

Ali Shorooghi has served as Senior Vice President, Marketing since November 2022. Throughout his tenure at ATEC, which commenced in 2017, Ali has served in marketing leadership roles, most recently as Vice President, Thoracolumbar Marketing. Prior to joining ATEC, Ali served on the founding team of Casetabs Inc., a cloud-based surgery coordination application that was acquired by Bain Capital. Ali joined Casetabs following a 7-year tenure at NuVasive, Inc., where he attained Marketing and Product Management roles that increased in responsibility. Ali received a Bachelor of Science in Industrial & Systems Engineering with an emphasis on Information & Operations Management from the University of Southern California.

MicrosoftTeams-image-99

Tyson Marshall

General Counsel & Corporate Secretary

Tyson Marshall


General Counsel & Corporate Secretary

Tyson Marshall has served as General Counsel & Corporate Secretary since July 2023. Mr. Marshall began his career with ATEC in 2017, first as Director of Legal Affairs (2017-2018) and then as Vice President, Associate General Counsel (2018-2023). Prior to joining ATEC, Mr. Marshall served as General Counsel & Corporate Secretary (2016-2017) and Associate General Counsel (2013-2016) of Mad Catz Interactive, Inc., a global provider of innovative interactive entertainment products. Prior to moving in-house, Mr. Marshall spent over ten years in private legal practice, including eight years with the international, full-service law firm Morrison & Foerster as a member of that firm’s Securities Litigation Enforcement and White Collar Defense group. Before joining Morrison & Foerster, Mr. Marshall was a securities and IP litigator at Fish & Richardson, an IP and commercial litigation firm. Mr. Marshall earned his law degree, magna cum laude, from the University of San Diego School of Law and his B.S. in Psychology from Brigham Young University.

Board of Directors

The Board of Directors has direct access to independent experts – lawyers, accountants and compensation experts – to turn to for counsel regarding specific company polices and activities.

The Audit Committee of the Board of Directors pre-approves all audit and permitted non-audited services, and reviews quarterly and year-end financial statements and associated press releases with our financial management and outside, independent auditors in advance of the filing or release of such documents.

The Compensation Committee of the Board of Directors approves all compensation-related matters involving Alphatec Spine’s senior management. In addition, The Compensation Committee of the Board of Directors approves all bonus plans and acts as the administrator of the company’s stock option plan and employee stock purchase plan.

Pat Miles

Patrick S. Miles

Chairman and Chief Executive Officer

 

 

PATRICK S. MILES


Chairman and Chief Executive Officer

Patrick S. Miles has served as Chairman and Chief Executive Officer of Alphatec Holdings and Alphatec Spine since October 2017. Mr. Miles has over 20 years of experience in the orthopaedic industry and most recently served, from September 2016 to September 2017, as the Vice Chairman of NuVasive. As Vice Chairman, Mr. Miles was responsible for enhancing the Company’s strategic plans for the future of spine surgery and supporting technology development. Mr. Miles served as a member of NuVasive’s Board of Directors since August 2016 until his resignation in September 2017. Prior to that, Mr. Miles served as NuVasive’s President and Chief Operating Officer from February 2015 to September 2016. He previously served as NuVasive’s President of Global Products and Services from October 2011 to January 2015, President of the Americas from January 2010 to September 2011, Executive Vice President of Product Marketing and Development from January 2007 to December 2009, Senior Vice President of Marketing from December 2004 to January 2007, and as its Vice President, Marketing from January 2001 to December 2004. Prior to those positions, he served as Director of Marketing for ORATEC Interventions, Inc., a medical device company, and as a Director of Marketing for Minimally Invasive Systems and Cervical Spine Systems for Medtronic Sofamor Danek, and held several positions with Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.

Mortimer Berkowitz III

Mortimer Berkowitz III

Lead Director, Chairman of the Nominating and Corporate Governance Committee

 

MORTIMER BERKOWITZ III


Lead Director, Chairman of the Nominating and Corporate Governance Committee

Mortimer Berkowitz III is the Lead Director and has served as a member of the Board of Directors since March 2005. From April 2007 through July 2011, he also served as the Chairman of the Board of Directors. He is currently President and CEO of InnovaHealth Partners, L.P. He is also a managing member of HGP, LLC, which is the general partner of HealthpointCapital Partners, LP, President, and a managing director of HealthpointCapital, LLC. He has held the position with HGP, LLC since its formation in August 2002, as well as the positions of managing director and member of the Board of Managers of HealthpointCapital, LLC since its formation in July 2002 and the position of President of HealthpointCapital, LLC since February 2005. Prior to joining HealthpointCapital, LLC, Mr. Berkowitz was managing director and co-founder of BPI Capital Partners, LLC, a private equity firm founded in 1990. Prior to 1990, Mr. Berkowitz spent 11 years in the investment banking industry with Goldman, Sachs & Co., Lehman Brothers Incorporated and Merrill Lynch & Co. Mr. Berkowitz serves on the Leadership Council of the Harvard School of Public Health.

Evan Bakst

Evan Bakst

Director

 

 

 

EVAN BAKST


Director

Evan Bakst has served as a Director since March 2018. Mr. Bakst is the Founder and Portfolio Manager of Treetop Capital since 2013, a fundamental, value-oriented investment firm focused primarily on small to midcap healthcare companies. Before launching Treetop, Mr. Bakst spent seven years (2005-2012) at Tremblant Capital, a long/short equity hedge fund, most recently as a Partner where he led the healthcare group. Prior to joining Tremblant, Mr. Bakst was a Principal at JPMorgan Partners, LLC (2000-2005), where he shared the day-to-day responsibility for managing the healthcare buyout practice. Previously, Mr. Bakst was a Managing Director at The Beacon Group, a private equity/M&A boutique and, prior to that, Mr. Bakst worked as a Consultant at Bain and Company, providing strategic and operational advice to a major healthcare company. Mr. Bakst is currently on the Board of Sonacare Medical, LLC, and was formerly on the Boards of Accordant Health Services, Cadent Holdings, Inc., FundsXpress Inc., Iasis Healthcare, MedQuest Associates, National Surgical Care, Quality Tubing Inc. and ValueOptions. Mr. Bakst earned a B.A. in Economics from the University of California, Berkeley, and an M.B.A. from the Harvard Business School.

Quentin Blackford

Quentin Blackford

Director, Member of the Audit and Compensation Committees

QUENTIN BLACKFORD


Director, Member of the Audit and Compensation Committees

Quentin Blackford has served as a Director since October 2017. He currently serves as the Chief Executive Officer of iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement of cardiac care. Prior to joining iRhythm in October 2021, Mr. Blackford served (from March 2021) as Chief Operating Officer and (from August 2017 to March 2021) as Chief Financial Officer of DexCom, Inc., a company focused on developing and marketing continuous glucose monitoring systems for ambulatory use by people with diabetes and by healthcare providers. Prior to joining DexCom, Inc. in August 2017, Mr. Blackford served since August 2016 as the Executive Vice President, Chief Financial Officer, Head of Strategy and Corporate Integrity of NuVasive, Inc., a medical device company focused on developing minimally disruptive surgical products and procedures for the spine. In this role, Mr. Blackford was responsible for leading NuVasive, Inc.’s Finance, Strategy and Corporate Development, Compliance and Regulatory functions. From August 2014 until August 2016, Mr. Blackford served as NuVasive, Inc.’s Executive Vice President and Chief Financial Officer. From July 2012 to August 2014, Mr. Blackford served as NuVasive, Inc.’s Executive Vice President of Finance and Investor Relations, and from January 2011 to June 2012, he served as NuVasive, Inc.’s Vice President, Finance. Mr. Blackford joined NuVasive, Inc. in 2009 as its Corporate Controller and was previously employed at Zimmer Holdings, Inc., including most recently as the Director of Finance and Controller for Zimmer’s Dental Division. Since May 2019, Mr. Blackford has served as a director of Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves. He obtained his Certified Public Accounting license (currently inactive) following the achievement of dual B.S. degrees in Accounting and Business Administration, with an emphasis in Accounting, from Grace College.

Dave DemskiHeadshot_ATEC_web

Dave Demski

Director, Member of the Audit Committee

DAVE DEMSKI


Director, Member of the Audit Committee

Dave Demski has served as a director since October 2023. Mr. Demski has over 20 years of direct spine industry experience. Most recently, Mr. Demski served on the Board of Directors of Globus Medical from 2003 to April 2022. From August 2017 to April 2022, Mr. Demski served as Globus Medical’s CEO and, from April 2019 to April 2022, its President. From 2003 to July 2008, Mr. Demski served as Globus Medical’s Chief Financial Officer and prior to that, as President, Emerging Technologies. Before joining Globus Medical, Mr. Demski founded Cornerstone Capital LBO Fund, a boutique leveraged buyout consultancy. Mr. Demski’s experience also includes serving as Vice President for Gilo Ventures, a Silicon Valley-based venture capital fund, and serving as Chief Operating Officer of Rendall and Associates, a telecommunications-focused consulting firm. He also managed regional and international distribution for Domino’s Pizza through the company’s growth in the late 1980s. Previously, Mr. Demski was an audit supervisor for Peat, Marwick, Mitchell & Company. Mr. Demski serves on the Board of Directors at Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction. Mr. Demski received a B.S. in Business Administration from the University of Michigan and an M.B.A. from Stanford Graduate School of Business.

Karen McGinnis

Karen McGinnis

Director, Chair of the Audit Committee, Member of the Compensation Committee

KAREN MCGINNIS


Director, Chair of the Audit Committee, Member of the Compensation Committee

Karen K. McGinnis has served as a Director since June 2019. Ms. McGinnis has over 30 years of experience, including serving in executive operational and finance roles at international public companies. In April 2021, Ms. McGinnis retired from Illumina, Inc., a leader in sequencing- and array-based solutions for genetic and genomic analysis, where she served as Chief Accounting Officer since November 2017. She also currently serves on the boards of Absci Corporation (Nasdaq: ABSI), a leading synthetic biology company enabling drug discovery and biomanufacturing of next generation biotherapeutics, Sonendo, Inc. (NYSE: SONX), a medical technology company focused on saving teeth from tooth decay and Biosplice Therapeutics, Inc., a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for major diseases. Prior to joining Illumina in November 2017, Ms. McGinnis served from February 2016 to April 2017 as Director, President and Chief Executive Officer of Mad Catz Interactive, Inc. a global provider of innovative interactive entertainment products. From June 2013 through February 2016, Ms. McGinnis served as Mad Catz’ Chief Financial Officer. Prior to joining Mad Catz, Ms. McGinnis served from November 2009 through May 2013 as Chief Accounting Officer of Cymer, Inc., the world’s leading supplier of light sources used in the photolithography process for semiconductor or chip manufacturing until its acquisition in 2013. Ms. McGinnis also served as Chief Accounting Officer for Insight Enterprises, Inc., from September 2006 until March 2009, its Senior Vice President of Finance from 2001 through September 2006 and its Vice President of Finance from 2000 through 2001. McGinnis is a Certified Public Accountant and earned her BBA in Accounting from the University of Oklahoma.

David Pelizzon Headshot

David Pelizzon

Director

 
 
 

David Pelizzon


Director

David Pelizzon has served as a member of the Board of Directors since June 2020.  Mr. Pelizzon currently (and since 2008) serves as President and member of the Managing Committee of Squadron Capital, an investment firm that primarily manages direct investments in operating companies, private equity funds and special situations. He also currently serves (since 2011) as a member of the Board of Directors of OrthoPediatrics, a company exclusively focused on advancing the field of pediatric orthopedics. From 2005 to 2008, Mr. Pelizzon served as the Managing Director of Precision Edge Holdings, a subsidiary of Colson Associates. Mr. Pelizzon is a retired U.S. Army officer who served nearly 30 years on active duty in airborne and special operations units. Mr. Pelizzon is a graduate of the U.S. Military Academy and earned advanced degrees from Harvard University and the U.S. Naval War College.

Jeff Rydin

Jeffrey P. Rydin

Director

 

 

 

JEFFREY P. RYDIN


Director, Member of the Nominating and Governance Committee

Jeffrey P. Rydin has served as a director since June 2017 and as a Special Advisor to the Board since September 2016.  Mr. Rydin has spent more than 27 years in the medical device and healthcare industries. Prior to joining Alphatec as Special Advisor to the Board, Mr. Rydin served as Chief Sales Officer of Ellipse Technologies, Inc., a medical technology company, from September 2015 until its purchase by NuVasive, Inc. in February 2016. Before joining Ellipse, Mr. Rydin served as President of Global Sales at NuVasive (October 2011 to March 2013), where he was responsible for NuVasive’s worldwide sales efforts, including the oversight of strategic sales development, sales administration, Area Vice Presidents and sales training. Prior to his position of President of Global Sales, he served as Executive Vice President of Sales—Americas and Senior Vice President, U.S. Sales since joining NuVasive in December 2005. Prior to joining NuVasive, Mr. Rydin served as Area Vice President, Sales (US Southeast region) at DePuy Spine, Inc. from January 2003 to December 2005. Mr. Rydin also served as Vice President of Sales at Orquest, Inc. from December 2001 to January 2003, Director of Sales at Symphonix Devices, Inc. from April 2000 to December 2001 and Director of Sales at General Surgical Innovations, Inc. from October 1996 to March 2000. Mr. Rydin also has served in various executive and leadership sales roles at General Surgical Innovations, Baxter Healthcare, US Surgical Corporation and Xerox. He currently serves as director of DuraStat, LLC. Mr. Rydin received a B.A. degree in Social Ecology from the University of California, Irvine.

Keith Valentine_Headshot_ATEC_web

Keith Valentine

Special Advisor to the Board of Directors

KEITH VALENTINE


Special Advisor to the Board of Directors

Keith Valentine has served as a Special Advisor to the Board of Directors since October 2023. Mr. Valentine has over 30 years of direct spine industry experience. He was most recently President and Chief Executive Officer of Orthofix, Inc., a global spine and orthopedics company, following its merger with SeaSpine, Inc. in 2023. Prior to the merger in 2023, Mr. Valentine served as Chief Executive Officer and President of SeaSpine, a global medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders, beginning in 2015. Prior to joining SeaSpine, Mr. Valentine served in various leadership capacities at NuVasive, Inc. from 2001-2015, including, most recently, President and Chief Operating Officer and, and before that, in senior executive roles in marketing, development and operations. From 1992 through 2002, Mr. Valentine held leadership positions with Medtronic Spine & Biologics, most recently as that company’s Vice President of Marketing. He currently serves on the Boards of SI-Bone, a developer of a minimally invasive surgical treatment for sacroiliac joint disorders, and Regentis Biomaterials, a tissue repair company focused on developing and commercializing an innovative hydrogel platform for the repair of damaged tissue. Mr. Valentine earned a B.B.A. from Western Michigan University and a B.S. in Pre-Medicine from the University of Michigan.

Ward Woods

Ward W. Woods

Director, Chairman of the Compensation Committee

 

 

WARD W. WOODS


Director, Chairman of the Compensation Committee

Ward W. Woods currently serves as Chairman of the Advisory Board of the Stanford Woods Institute, as Chair Emeritus and trustee of the Wildlife Conservation Society and as a trustee of the David & Lucille Packard Foundation. He is a member of the Council on Foreign Relations. He is former President and Chief Executive Officer of Bessemer Securities Corporation and Founding Partner of Bessemer Holdings, L.P. (1989-2003), a private equity firm. From 1978 to 1989, Mr. Woods was a senior partner and member of the Management Committee of Lazard Freres & Company. Prior to joining Lazard, Mr. Woods was a Managing Director and a Partner of Lehman Brothers and was co-head of the Corporate Finance Department. He joined Lehman Brothers in 1967 and was elected partner in 1973. Upon graduation from Stanford University in 1964, Mr. Woods joined the Fay Improvement Company, an engineering construction and real estate firm in San Francisco and in 1966 became its general manager, acting in that capacity until the company was sold in 1967. He is a former Trustee of Stanford University, former Chairman of The Stanford Management Company and a former trustee of the National Fish and Wildlife Foundation. Mr. Woods has also served as former Governor and Treasurer of The Nature Conservancy, Vice-Chair and trustee of The Asia Society and a trustee of The Boys Club of New York.

Contact Us

RLOCATIONS

U.S. HEADQUARTERS
ATEC Spine, Inc.
1950 Camino Vida Roble
Carlsbad, CA 92008
P: +1-760-431-9286
P: +1-800-922-1356

FRANCE HEADQUARTERS
EOS imaging

32 Rue Blanche
Paris, France 75009
P: +33 1 55 25 60 60

NEW ZEALAND
1 Prosford St
Ponsonby, Auckland 1011
P: +64 9 886 3356
P: +0800 843 004

AUSTRALIA
101 Cremorne Street
Cremorne, Victoria 3121
P: +61 3 9001 8576
P: +1800 319 409

CUSTOMER SERVICE

P: +1-800-922-1356 [Tollfree]
P: +1-760-431-9286
F:  +1-800-431-9722
Hours of Operation:
Mon-Fri 6am - 5:30pm PST

PEOPLE AND CULTURE

P: +1-760-431-9286

INVESTOR RELATIONS

Tina Jacobsen, CFA
P:
+1-760-494-6790
E:
ir@atecspine.com

Have a question?

If you have any questions regarding regarding how we store your data, please refer to our Privacy Policy or Contact Us through this form.
=